Andean Precious Metals (CVE:APM) Reaches New 1-Year High Following Insider Buying Activity

Andean Precious Metals Corp. (CVE:APM) shares reached a new 52-week high during mid-day trading on Thursday after an insider bought additional shares in the company. The stock traded as high as C$1.53 and last traded at C$1.53, with a volume of 111240 shares trading hands. The stock had previously closed at C$1.45.

Specifically, insider 2176423 Ontario Ltd. acquired 213,800 shares of Andean Precious Metals stock in a transaction that occurred on Wednesday, October 2nd. The shares were purchased at an average cost of C$1.38 per share, for a total transaction of C$294,530.88.

Analyst Ratings Changes

Separately, Desjardins boosted their price objective on shares of Andean Precious Metals from C$1.60 to C$1.70 and gave the company a “buy” rating in a report on Tuesday, September 3rd.

Andean Precious Metals Stock Up 7.6 %

The company has a market cap of C$233.00 million, a PE ratio of 4.16 and a beta of 1.13. The stock’s fifty day moving average price is C$1.10.

Andean Precious Metals (CVE:APM) last issued its quarterly earnings results on Tuesday, August 13th. The company reported C$0.08 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of C$0.08. The company had revenue of C$95.47 million for the quarter. Andean Precious Metals had a net margin of 23.75% and a return on equity of 41.08%. Equities research analysts expect that Andean Precious Metals Corp. will post 0.3792135 EPS for the current fiscal year.

About Andean Precious Metals

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.